KDR and neoplasm: VEGFR2, the receptor of vascular endothelial growth factor (VEGF), is principally responsible for mediating the mitogenic-, angiogenic- and permeability-enhancing effects of VEGF and potentially plays a role in stimulating tumour growth and metastasis8.